July 10, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
The Alzheimer’s Association International Conference 2026 will meet in London, with breakthrough research planned across workshops, lectures and plenary sessions. Laura Nisenbaum, PhD, interim chief science officer of the Alzheimer’s Drug Discovery Foundation, will be at the event, which runs from July 12 to July 15. Healio spoke with her about what she’s looking forward
July 10, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Dementia study replicates promising outcomes following risk-reduction strategies

NeuroTherapia to Present Phase 2a Alzheimer's Disease Clinical Data at the AAIC 2026 Conference in London, UK

Biogen Alzheimer's drug slowed decline at rates on par with approved therapies, study shows

All eyes on data on Biogen's tau therapy

Questions linger over Biogen's tau drug for Alzheimer's, as low dose reports better results

Tau in the spotlight at Alzheimer’s conference

/C O R R E C T I O N — Eli Lilly and Company/

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2026 LIFESTYLE PROGRAM IMPROVES BRAIN HEALTH AMONG OLDER ADULTS AT RISK FOR DEMENTIA ACROSS LATIN AMERICA

INDIANA UNIVERSITY AND PHARMATROPHIX PRESENT FINDINGS ON PERFORMANCE OF ORAL THERAPEUTIC, LM11A-31, TO REDUCE DECLINE OF BRAIN FUNCTIONAL-NETWORK CONNECTIVITY IN ALZHEIMER'S DISEASE

Alzheon to Present New Evidence of Neurovascular Protection and Preserved Brain Microstructure from Oral Valiltramiprosate Trials in APOE4/4 Alzheimer’s Patients at AAIC 2026 Conference in London

RESEARCH ADVANCES FROM THE 2026 ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE

Clinical Trials on Alzheimer's Disease Conference and Alzheimer's Drug Discovery Foundation Partner to Advance Emerging Biotech…

In this Healio video, Christopher Lock, MD, discusses advances in Alzheimer’s disease treatment and diagnosis presented at the…

We are living in an exciting new era for Alzheimer’s treatment. For the first time, therapies can slow the disease for some…

Christopher Lock, MD, spoke with Healio about takeaways on the impact of lifestyle factors on Alzheimer’s disease presented at…

Healio brings you the highlights from the Alzheimer’s Association International Conference. Refer back to this page often for the…